Skip to main content

Table 3 Determinants of malaria treatment delay in the northwestern zone of Tigray, Northern Ethiopia, 2018

From: Determinants of malaria treatment delay in northwestern zone of Tigray region, Northern Ethiopia, 2018

Variable

Category

Cases n = 161

No (%)

Control n = 161

No (%)

COR

AOR

Sex

Female

116 (72)

105 (65.2)

1.38 (0.86–2.21)*

0.81 (0.46–1.45)

Male

45 (28)

56 (34.8)

1.00

1.00

Age

< 7

17 (10.6)

27 (16.8)

1.00

1.00

7–14

19 (11.8)

21 (13)

1.44 (0.60–3.42)

1.61 (0.52–4.98)

15–45

110 (68.3)

101 (62.7)

1.73 (0.89–3.36)

0.93 (0.28–3.07)

> 45

15 (9.3)

12 (7.5)

1.98 (0.75–5.25)

1.1 (0.25–4.81)

Address

Laelay Adyabo

91 (56.5)

90 (55.9)

1.48 (0.84–2.6)*

1.46 (0.73–2.92)

Tahtay Adyabo

42 (26.1)

30 (18.6)

2.05 (1.05–4.01)*

2.84 (1.29–6.27)**

Asgede Tsimbla

28 (17.4)

41 (25.5)

1.00

1.00

Educational status

No formal education

85 (52.8)

71 (44.1)

1.73 (0.88–3.41)*

2.39 (1.09–5.22)**

Primary education

58 (36)

64 (39.8)

1.31 (0.65–2.63)

1.58 (0.74–3.41)

Above secondary

18 (11.2)

26 (16.1)

1.00

1.00

Medicine taking in home

Yes

10 (6.4)

20 (12.4)

0.47 (0.21–1.03)*

0.43 (0.18–1.02)

No

151 (93.6)

141 (87.6)

1.00

1.00

Who decide for health care seeking

Patients

82 (50.9)

72 (44.7)

1.85 (0.92–3.72)*

2.38 (1.09–5.2)**

Father

63 (39.1)

63 (39.1)

1.62 (0.8–3.32)*

2.52 (1.13–5.62)**

Mother

16 (9.9)

26 (16.1)

1.00

1.00

Dead family member in the last month

Yes

2 (1.2)

6 (3.7)

0.32 (0.06–1.63)*

0.43 (0.08–2.28)

No

159 (98.8)

155 (96.3)

1.00

1.00

Knowledge on malaria symptoms

Good

74 (46)

55 (34.2)

1.64 (1.05–2.57)*

2.02 (1.21–3.39)**

Poor

87 (54)

106 (65.8)

1.00

1.00

Knowledge on malaria transmission

Good

142 (88.2)

133 (82.6)

1.57 (0.84–2.95)*

1.15 (0.53–2.48)

Poor

19 (11.8)

28 (17.4)

1.00

1.00

Knowledge of malaria at risk population

Good

62 (38.5)

82 (50.9)

0.6 (0.39–0.94)*

0.83 (0.45–1.52)

Poor

99 (61.5)

79 (49.1)

1.00

1.00

  1. * Significant variables at P-value < 0.2
  2. ** Significant variable at P-value ≤ 0.05